The Oncology Institute, Inc.
TOI
$4.49
$0.030.67%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 14.75% | 4.13% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 14.75% | 4.13% | |||
| Cost of Revenue | 17.38% | 1.78% | |||
| Gross Profit | 1.46% | 17.85% | |||
| SG&A Expenses | 6.03% | 2.08% | |||
| Depreciation & Amortization | 1.18% | 4.51% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.61% | 1.89% | |||
| Operating Income | -13.12% | 16.92% | |||
| Income Before Tax | 12.48% | -48.57% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 13.15% | -48.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 13.15% | -48.57% | |||
| EBIT | -13.12% | 16.92% | |||
| EBITDA | -15.74% | 20.50% | |||
| EPS Basic | 28.01% | -45.70% | |||
| Normalized Basic EPS | 11.82% | -16.55% | |||
| EPS Diluted | 28.52% | -43.15% | |||
| Normalized Diluted EPS | 11.82% | -16.55% | |||
| Average Basic Shares Outstanding | 20.89% | 1.91% | |||
| Average Diluted Shares Outstanding | 20.89% | 1.91% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||